Peer-reviewedCC BYJournal of clinical medicine
Beta-Blocker Therapy After Acute Myocardial Infarction
Related
- Qili Qiangxin capsule as adjunctive therapy for heart failure after acute myocardial infarction: a GRADE-assessed systematic review and meta-analysis of randomised controlled trials
- ECG-Derived Synthetic Left Ventricular Mechanics Predict Mortality After Acute Myocardial Infarction and Fatal Myocardial Infarction in the General Population
- Ivabradine for inappropriate sinus node-mediated tachycardia associated with hemodynamic deterioration after acute myocardial infarction: A case report
- Right Coronary Artery Thrombosis Causing ST-Elevation Myocardial Infarction After a Coronary Artery Disease Reporting and Data System Score of 0, With Disseminated Intravascular Coagulation During Idiopathic Acute Pancreatitis: A Case Report
- Prevalence, causes, and predictors of 30-day readmissions after acute myocardial infarction with ventricular arrhythmias: a cohort study using the 2016–2017 national readmissions database
BibTeX
@article{anon2026betablocker,
title = {{Beta-Blocker Therapy After Acute Myocardial Infarction}},
journal = {Journal of clinical medicine},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13666520},
note = {CC BY},
}
RIS
TY - JOUR
TI - Beta-Blocker Therapy After Acute Myocardial Infarction
PY - 2026
DA - 2026/09/29
JO - Journal of clinical medicine
UR - https://europepmc.org/article/PMC/PMC13666520
SN - 2077-0383
ER -